Survey of Ophthalmology
Volume 45, Issue 1 , Pages 77-83 , 15 July 2000

Node Way Out

  • Michael S Vaphiades, DO

      Affiliations

    • Departments of Ophthalmology and Neurology, University of Arkansas for Medical Sciences, Little Rock, AR USA
    • ,
  • Harry Brown, MD

      Affiliations

    • Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR USA
    • ,
  • Scott M Whitcup, MD

      Affiliations

    • The National Eye Institute, National Institutes of Health, Bethesda, MD, USA

References 

  1. Alexander KR, Fishman GA, Peachey NS, et al.  Response defect in paraneoplastic night blindness with cutaneousmalignant melanoma. Invest Ophthalmol Vis Sci. 1992;33:477–483
  2. Andréasson S, Ponjavic V, Ehinger B. Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy. Acta Ophthalmol. 1993;71:487–490
  3. Aptsiauri N, Jordan BL, Heckenlively J. Anti-recoverin immunoreactivity in patients with retinal degeneration without systemic malignancy. Invest Ophthalmol Vis Sci. 1998;39:S363;[abstract]
  4. Arai J, Kikuchi T, Katai N, et al.  Tubby-like protein 1 is one of the retinal autoantigens in a patient with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1998;39:S724;[abstract]
  5. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol. 1988;106:307–311
  6. Buchanan TAS, Gardiner TA, Archer DB. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol. 1984;97:277–287
  7. Dalakas MC. The use of intravenous immunoglobulin for neurologic diseases. Neurology. 1998;551:S1–S45
  8. Foster CS, Ahmed AR. Intravenous Immunoglobulin therapy for ocular cicatricial pemphigoid (a preliminary study). Ophthalmology. 1999;106:2136–2143
  9. Gehrs K, Tiedeman J. Hemeralopia in an older adult. Surv Ophthalmol. 1992;37:185–189
  10. Grunwald GB, Klein R, Simmonds MA, Kornguth SE. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Lancet. 1985;1:658–661
  11. Grunwald GB, Kornguth SE, Towfighi J, et al.  Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer. 1987;60:780–786
  12. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin. Arch Ophthalmol. 1999;117:471–477
  13. Heckenlively JR, Oversier JJ, Jordan BL, et al.  CAR-like syndrome (Progressive panretinal degenerations not associated with cancer but with anti-recoverin (and other) anti-retinal antibodies). Invest Ophthalmol Vis Sci. 1998;39:S216;[abstract]
  14. Heckenlively JR, Jordan BL, Aptsiauri N. Associated of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127:565–573
  15. Jacobson DM. Paraneoplastic diseases of neuro-ophthalmologic interest. In:  Miller NR,  Newman JN editor. Walsh & Hoyt's Clinical Neuro-Ophthalmology. Baltimore, MD: Williams & Wilkins; 1998;p. 2497–2551
  16. Jordon BL, Dawson WW, Fang T, et al.  Functional retinal abnormalities among cancer patients. Invest Ophthalmol Vis Sci. 1998;39:S402;[abstract]
  17. Keltner JL, Thirkill CE. Cancer-associated retinopathy vs. recoverin-associated etinopathy. Am J Ophthalmol. 1998;126:296–302[editorial]
  18. Keltner JL, Thirkill CE: Commonality and diversity in the clinical and immune findings of melanoma-associated retinopathy (MAR) patients [abstract]. 24th Annual North American Neuro-Ophthalmology Society Meeting, Orlando, Florida, March 22, 1998, p 20
  19. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration (possible autoimmune disorder). Arch Ophthalmol. 1983;101:564–569
  20. Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110:48–53
  21. Keltner JL, Thirkill CE. The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol. 1999;19:71–83
  22. Kikuchi T, Arai J, Shibuki H, et al.  Isolation and characterization of a new retinal and neuronal autoantigen recognized by serum of a patient with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1998;39:S724;[abstract]
  23. Kim RY, Retsas S, Fitzke FW, et al.  Cutaneous melanoma-associated retinopathy. Ophthalmology. 1994;101:1837–1843
  24. Kiratli H, Thirkill CE, Bilgif S, et al.  Paraneoplastic retinopathy associated with metastic cutaneous melanoma of unknown primary site. Eye. 1997;11:889–892
  25. Klingele TG, Burde RM, Rappazzo JA, et al.  Paraneoplastic retinopathy. J Clin Neuro Ophthalmol. 1984;4:239–245
  26. Kornguth SE, Klein R, Appen R, Choate J. Occurrence of antiretinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982;50:1289–1293
  27. Kornguth SE, Kalinke T, Grunwald GB, et al.  Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 1986;46:2588–2595
  28. Machnicki DA, Fox DA, Adamus FG. Anti-recoverin antibody induces photoreceptor and bipolar cell apoptosis. Invest Ophthalmol Vis Sci. 1998;39:S363;[abstract]
  29. Merimsky O, Shoenfeld Y, Chaitchik S, et al.  Antigens and antibodies in malignant melanoma. Tumour Biol. 1994;15:188–202
  30. Milam AH, Saari JC, Jacobson SG, et al.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:91–100
  31. Mizener JB, Kimura AE, Adamus G, et al.  Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol. 1997;123:607–618
  32. Ogawa KI, Maeda T, Ikeda Y, et al.  Both 70kDa and 26 kDa proteins are autoantigens found in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1998;39:S817;[abstract]
  33. Okel BB, Thirkill CE, Anderson K. An unusual case of melanoma-associated retinopathy. Ocular Immunol Inflam. 1995;3:121–127
  34. Pestronk, A: Paraneoplastic Neuropathies. Proceedings from the American Neurologic Association Annual Meeting, Montreal, Quebec, Canada, October 18–21, 1998
  35. Potter MJ, Thirkill CE, Dam OM, et al.  Clinical and Immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106:2121–2125
  36. Qureshi AI, Choudhry MA, Akbar MS, et al.  Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology. 1999;52:629–632
  37. Remulla JFC, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol. 1995;113:854–855
  38. Ripps H, Carr RE, Siegel IM, Greenstein VC. Functional abnormalities in vincristine-induced night blindness. Invest Ophthalmol Vis Sci. 1984;25:787–794
  39. Rosenbaum JT, George RK, Gordon C. The treatment of refractory uveitis with intravenous immunoglobulin. Am J Ophthalmol. 1999;127:545–549
  40. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81:606–613
  41. Singh AD, Milam AH, Shields CL, et al.  Melanoma-associated retinopathy. Am J Ophthalmol. 1995;119:369–370
  42. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372–375
  43. Visser LH, Schmitz PIM, Meulstee J, et al.  Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barre Syndrome Study Group. Neurology. 1999;53:598–604
  44. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology. 1994;101:1236–1243
  45. Whitcup SM, Vistica BP, Milam AH, et al.  Recoverin-associated retinopathy (a clinically and immunologically distinctive disease). Am J Ophthalmol. 1998;126:230–237

☆ The authors have no proprietary or commercial interest in any product or concept discussed in this article.

☆☆ This work was supported in part by an unrestricted grant from the Research to Prevent Blindness, Inc., New York, NY.

★ Reprints are not available.

PII: S0039-6257(00)00133-8

Survey of Ophthalmology
Volume 45, Issue 1 , Pages 77-83 , 15 July 2000

Article Tools

* Image Usage & Resolution